Bafna Pharmaceuticals Limited (BAFNAPH) — Cash Flow Reinvestment Rate
Bafna Pharmaceuticals Limited (BAFNAPH) has a Cash Flow Reinvestment Rate of 1.76x as of September 2025, reinvesting Rs164.17 Million (capex Rs164.17 Million ) from operating cash flow of Rs93.12 Million. See Bafna Pharmaceuticals Limited free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Bafna Pharmaceuticals Limited Cash Flow Reinvestment Rate (2007–2026)
Historical reinvestment intensity for Bafna Pharmaceuticals Limited across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Bafna Pharmaceuticals Limited.
Annual Cash Flow Reinvestment Rate for Bafna Pharmaceuticals Limited (2007–2026)
Year-by-year capital reinvestment analysis for Bafna Pharmaceuticals Limited. See Bafna Pharmaceuticals Limited financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 2.11x | Rs249.03 Million | Rs118.27 Million | Rs249.03 Million | ▼ -4.4% |
| 2025 | 2.20x | Rs430.23 Million | Rs195.29 Million | Rs218.60 Million | ▼ -31.8% |
| 2024 | 3.23x | Rs306.32 Million | Rs94.85 Million | Rs155.78 Million | ▲ +1.8% |
| 2023 | 3.17x | Rs157.11 Million | Rs49.52 Million | Rs82.19 Million | ▲ +137.8% |
| 2022 | 1.33x | Rs129.80 Million | Rs97.28 Million | Rs75.41 Million | ▼ -47.3% |
| 2016 | 2.53x | Rs23.07 Million | Rs9.11 Million | Rs23.07 Million | ▲ +246.7% |
| 2015 | 0.73x | Rs77.90 Million | Rs106.65 Million | Rs77.90 Million | ▼ -33.1% |
| 2014 | 1.09x | Rs17.53 Million | Rs16.06 Million | Rs17.53 Million | ▲ +1778.7% |
| 2013 | 0.06x | Rs21.28 Million | Rs366.32 Million | Rs21.28 Million | ▼ -96.9% |
| 2007 | 1.85x | Rs187.01 Million | Rs101.06 Million | Rs187.01 Million | — |